BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34007838)

  • 21. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
    Li Y; He HC; Zhou DL; Liu Q; Zhang X; Yang XH; Ye ZL; Peng JL; Tang T; Su X; He CY
    J Gastroenterol Hepatol; 2021 Jan; 36(1):233-239. PubMed ID: 32453900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
    Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
    Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
    Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
    Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
    Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
    Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
    Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control study.
    Wang XZ; Tang WZ; Su QY; Yao JG; Huang XY; Long QQ; Wu XM; Xia Q; Long XD
    Cancer Med; 2019 Dec; 8(18):7869-7880. PubMed ID: 31663692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.
    Tan C; Liu S; Tan S; Zeng X; Yu H; Li A; Bei C; Qiu X
    PLoS One; 2015; 10(3):e0119210. PubMed ID: 25739100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.
    Binh MT; Hoan NX; Giang DP; Tong HV; Bock CT; Wedemeyer H; Toan NL; Bang MH; Kremsner PG; Meyer CG; Song LH; Velavan TP
    Sci Rep; 2020 Feb; 10(1):2797. PubMed ID: 32071406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis.
    Hassanin OM; El-Masry TM; El-Baz A; Adel-Abou-Zaghla HM
    Egypt J Immunol; 2017 Jan; 24(1):143-152. PubMed ID: 29120586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
    Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
    Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of
    Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
    Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between a single nucleotide polymorphism of the XRCC1 gene and hepatocellular carcinoma susceptibility in the Chinese Han population.
    Li XF; Chen YX; Ye WW; Tao XF; Zhu JH; Wu S; Lou LQ
    Genet Mol Res; 2014 Jan; 13(1):160-6. PubMed ID: 24446299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS; Im JP; Min BH; Kim HD; Jeong JB; Yoon JH; Kim CY; Kim MS; Kim JY; Jung JH; Kim LH; Park BL; Shin HD
    Exp Mol Med; 2003 Jun; 35(3):196-202. PubMed ID: 12858019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
    J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.
    Tannapfel A; Sommerer F; Benicke M; Katalinic A; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
    Gut; 2003 May; 52(5):706-12. PubMed ID: 12692057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.